Treatment of Toxic Epidermal Necrolysis with the Combination of Infliximab and High-Dose Intravenous Immunoglobulin

Publisher： Karger

E-ISSN： 1421-9832|224|2|134-139

ISSN： 1018-8665

Source： Dermatology, Vol.224, Iss.2, 2012-05, pp. : 134-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toxic Epidermal Necrolysis Treated with Intravenous High-Dose Immunoglobulins: Our Experience

By  

Dermatology, Vol. 203, Iss. 1, 2001-09 ,pp. : 45-49

Karger

Access to resources Recommend Favorite

Toxic Epidermal Necrolysis Associated with Treatment for Preterm Labor

By  

Dermatology, Vol. 196, Iss. 4, 1998-06 ,pp. : 461-462

Karger

Access to resources Recommend Favorite

Transient and Partial Effect of High-Dose Intravenous Immunoglobulin in Polyarteritis nodosa

By  

Dermatology, Vol. 203, Iss. 2, 2001-09 ,pp. : 188-189

Karger

Access to resources Recommend Favorite

Successful Treatment of Progressive Vitiligo with High-Dose Intravenous Methylprednisolone ‘Pulse’ Therapy

By  

Dermatology, Vol. 199, Iss. 3, 1999-11 ,pp. : 261-262

Karger

Access to resources Recommend Favorite

Effect of High-Dose Intravenous Immunoglobulin Therapy in Stevens-Johnson Syndrome: A Retrospective, Multicenter Study

By  

Dermatology, Vol. 207, Iss. 1, 2003-07 ,pp. : 96-99

Karger

Access to resources Recommend Favorite